Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
32,552,132
-
Share change
-
-79,676
-
Total reported value
-
$219,088,519
-
Put/Call ratio
-
53%
-
Price per share
-
$6.73
-
Number of holders
-
79
-
Value change
-
-$1,445,645
-
Number of buys
-
35
-
Number of sells
-
24
Institutional Holders of AVADEL PHARMACEUTICALS - COM (AVDL) as of Q2 2021
As of 30 Jun 2021 AVADEL PHARMACEUTICALS - COM (AVDL) had 79 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 32,552,132 shares of stock of the company.
Largest 10 holders included RTW INVESTMENTS, LP, Avoro Capital Advisors LLC, BRANDES INVESTMENT PARTNERS, LP, Vivo Capital, LLC, Polar Capital Holdings Plc, COWEN AND COMPANY, LLC, GENDELL JEFFREY L, RENAISSANCE TECHNOLOGIES LLC, JANUS HENDERSON GROUP PLC, and FRAZIER MANAGEMENT LLC.
This table shows 79 institutional shareholders of the security as of 30 Jun 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.